OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES Stock

Certificat

DE000GG6RZF2

Real-time BOERSE MUENCHEN 14:27:21 2024-05-23 EDT
0.196 EUR -7.11% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES
Current month+28.95%
1 month+16.67%
Date Price Change
24-05-23 0.196 -7.11%
24-05-22 0.211 0.00%
24-05-21 0.211 -3.21%
24-05-20 0.218 -0.91%
24-05-17 0.22 0.00%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 02:27 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GG6RZF
ISINDE000GG6RZF2
Date issued 2024-04-16
Strike 74.25 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.22
Lowest since issue 0.146

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
94.44 USD
Average target price
107.9 USD
Spread / Average Target
+14.24%
Consensus